
United States · Health startup
dosist is a modern wellness company based in Santa Monica, California, focused on helping people manage their health through dose-controlled cannabis therapy.
Funding reportedLast round: Corporate round
dosist is a modern wellness company based in Santa Monica, California, focused on helping people manage their health through dose-controlled cannabis therapy.
Founded in 2016, dosist offers science-backed formulations and proprietary delivery devices that ensure safe and consistent cannabinoid experiences. The company emphasizes ethical production, using medical-grade, recyclable materials and rigorous testing to guarantee pesticide-free products. The flagship product is the dose-controlled vape pen, which delivers precise doses of cannabis compounds tailored for specific wellness goals, such as relief from pain, support for sleep, and mood elevation. In addition to vape pens, dosist has introduced the Dose Dial, an edible delivery device that dispenses controlled doses of cannabis tablets. The company also operates a wellness boutique in Venice, California, where customers can receive personalized recommendations and purchase products in a modern environment. Recognized for its innovation, dosist has been featured in *Time* Magazine and *Fast Company*, and it aims to expand its reach into the Canadian cannabis market.
Funding, as reported
What they build
Known for
hardwareonline advertisingconsumerscustomer engagementlab-tested cannabisdigital brandingmarketingglobal wellness branddistributionmanufacturinglocal seocannabis for painsustainable materialsrapid-onset technologycannabis for focusemail marketing
Built with from their website
Google MapsWordPress.orgFont AwesomeMailChimpGoogle WorkspaceCloudFlareViewport MetaGoogle PlacesElement UIZencoder
All in One SEOGoogle MeetGoogle Maps PlatformCloudFlare CDNTwilio SendGrid Email Marketing CampaignsPriority HintsGoogle Font APICloudflare Insights
Add your raise, your deck and your story, and put dosist in front of investors. Or tell us what we have wrong.